The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Phycocyanin: A Potential Drug for Cancer Treatment
Open accessAbstract
Phycocyanin isolated from marine organisms has the characteristics of high efficiency and low toxicity, and it can be used as a functional food. It has been reported that phycocyanin has anti-oxidative function, anti-inflammatory activity, anti-cancer function, immune enhancement function, liver and kidney protection pharmacological effects. Thus, phycocyanin has an important development and utilization as a potential drug, and phycocyanin has become a new hot spot in the field of drug research. So far, there are more and more studies have shown that phycocyanin has the anti-cancer effect, which can block the proliferation of cancer cells and kill cancer cells. Phycocyanin exerts anti-cancer activity by blocking tumor cell cell cycle, inducing tumor cell apoptosis and autophagy, thereby phycocyanin can serve as a promising anti-cancer agent. This review discusses the therapeutic use of phycocyanin and focuses on the latest advances of phycocyanin as a promising anti-cancer drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity
Hahn-Windgassen, A., Nogueira, V., Chen, C.-C., Skeen, J. E., Sonenberg, N., & Hay, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502876200 · Cited by 539
Chen, T., & Wong, Y.-S. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf073399k · Cited by 157
Anti-inflammatory activity of c-phycocyanin in lipopolysaccharide-stimulated RAW 264.7 macrophages
Cherng, S.-C., Cheng, S.-N., Tarn, A., & Chou, T.-C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.09.009 · Cited by 136
Cyanobacterial phycobilisomes and phycobiliproteins
Stadnichuk, I. N., Krasilnikov, P. M., & Zlenko, D. V. (2015) · Microbiology · doi:10.1134/s0026261715020150 · Cited by 105
Cytotoxicity of algae extracts on normal and malignant cells
Bechelli, J., Coppage, M., Rosell, K., & Liesveld, J. (2011) · Leukemia Research and Treatment · doi:10.4061/2011/373519 · Cited by 52
Wan, D.-H., Zheng, B.-Y., Ke, M.-R., Duan, J.-Y., Zheng, Y.-Q., Yeh, C.-K., & Huang, J.-D. (2017) · Chemical Communications · doi:10.1039/c6cc09541k · Cited by 38
Cited by
Natural Products as Anticancer Agents: Current Status and Future Perspectives
Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022) · Molecules · doi:10.3390/molecules27238367 · Cited by 607
Phycobiliproteins from cyanobacteria: Chemistry and biotechnological applications
Pagels, F., Guedes, A. C., Amaro, H. M., Kijjoa, A., & Vasconcelos, V. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.010 · Cited by 426
Ashaolu, T. J., Samborska, K., Lee, C. C., Tomas, M., Capanoglu, E., Tarhan, Ö., Taze, B., & Jafari, S. M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.11.064 · Cited by 184
Therapeutic Uses of Red Macroalgae
Ismail, M. M., Alotaibi, B. S., & EL-Sheekh, M. M. (2020) · Molecules · doi:10.3390/molecules25194411 · Cited by 118
Spirulina for Skin Care: A Bright Blue Future
Ragusa, I., Nardone, G. N., Zanatta, S., Bertin, W., & Amadio, E. (2021) · Cosmetics · doi:10.3390/cosmetics8010007 · Cited by 104
Cyanotherapeutics: An emerging field for future drug discovery
Tiwari, A. K., & Tiwari, B. S. (2020) · Applied Phycology · doi:10.1080/26388081.2020.1744480 · Cited by 49
Prasetiya, F. S., Destiarani, W., Prihastaningtyas, I. R. C., Agung, M. U. K., & Yusuf, M. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.10012 · Cited by 3
Kamel, M., Aleya, S., Louzon, M., & Aleya, L. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04113-0 · Cited by 2
Metadata
- Authors
- Jiang, L., Wang, Y., Yin, Q., Liu, G., Liu, H., Huang, Y., & Li, B.
- Venue
- Journal of Cancer
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 8
- Issue
- 17
- Pages
- 3416-3429
- ISSN
- 1837-9664 (ISSN-L)
- OpenAlex
- W2756555938
- Cited by
- 238
- References
- 7
- FWCI
- 13.26
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.